# Efficacy, safety, and tolerability of secukinumab in patients with active ankylosing spondylitis: a randomized, double-blind phase 3 study, MEASURE 3

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-safety-and-tolerability-of-secukinumab-in-patients-with-active/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Karel Pavelka,Alan Kivitz,Eva Dokoupilová,Ricardo Blanco,Marco Maradiaga,Hasan Tahir,Luminita Pricop,Mats Andersson,Aimee Readie,Brian Porter |
| Citations | 234 |
| DOI | 10.1186/s13075-017-1490-y |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://arthritis-research.biomedcentral.com/track/pdf/10.1186/s13075-017-1490-y |
| OpenAlex ID | https://openalex.org/W2780640950 |
| PMID | 29273067 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Ricardo Blanco](https://scholariq.org/researchers/ricardo-blanco/)

## Paper journal

- [Arthritis Research & Therapy](https://scholariq.org/journals/arthritis-research-and-therapy/)

## Paper primary topic

- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)

## Paper topics

- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Autoimmune and Inflammatory Disorders Research](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.